Hanmi to register patent for a modified G-CSF in Europe.

Hanmi announced on Aug. 19 that the patent for the production and process of "a modified stimulant (G-CSF) of human granulocyte colony", a protein for the treatment of leukocytopenia accompanied by the chemotherapy was completed in Europe.

Hanmi said that the candidated compound called "HM-10411" showed about 50% higher effective and significant expression volume for the granulocyte colony p...